13 Active TrialsInfusion CenterMedium Practice
2 MS centers statewide · Ranked #1 in Oklahoma for clinical trials · #1 in Oklahoma for provider count
What kind of place is this?
Research FocusedComprehensive Care TeamInfusion On-Site
You'll find an academic MS center that brings together neurology, rehabilitation, and support services for ongoing care. You can expect access to on-site infusion, visual testing, and a team that helps coordinate treatment across specialties.
Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access4/5
Support Services5/5
Clinical Trials & Research4/5
Insurance & Navigation Help3/5
Scheduling & Virtual Care2/5
About OMRF Multiple Sclerosis Center of Excellence
This center stands out for combining academic MS care with on-site infusion services, neuro-ophthalmology testing, and MS-focused rehabilitation. It also brings together neurologists, physician assistants, physical therapy, and social work in a single-location care team.
OMRF Multiple Sclerosis Center of Excellence serves people with multiple sclerosis through a multidisciplinary team and a range of MS-specific services. You can receive neurological consultation, disease management, neuro-ophthalmology care, mobility assessments, spasticity treatment, and infusion services at the center. The team also offers MS-centric physical therapy, education, and coordination of care to support your ongoing treatment. Its affiliation with the Oklahoma Medical Research Foundation reflects a strong academic and specialty-care focus.
Good to know
- Doctor referral is required before you become a patient.
- Free reserved patient parking is available in Garage 15T.
- Use the North Entrance off NE 15th St. for patient access.
- Patient forms are available to download before your visit.
- Financial assistance and transportation application forms are available for patients.
OMRF Multiple Sclerosis Center of Excellence is an academic MS center in Oklahoma City that focuses on caring for people living with multiple sclerosis. It is affiliated with the Oklahoma Medical Research Foundation, with a team that includes neurologists, physician assistants, physical therapy, and social work. You can also access on-site infusion care, visual testing, and MS-focused rehabilitation support in one place. The center combines disease management with education and care coordination to help make ongoing treatment easier to navigate.
Featured Care Team Members
Gabriel Pardo, M.D.
Yang Mao-Draayer, M.D., Ph.D.
Chelsea Berkley, M.D.
Tony Sharp, PA
Jennifer Smith, PA
Bobbette Miller, DPT, NCS, Ph.D.
Lauren Still, LCSW
Chelsea Berkley, MD
Active MS Prescriber
Gabriel Pardo, MD
Active MS Prescriber
Specialized Programs
MS-centric physical therapy
Mobility assessments
Disease education
Coordination of care
Services & Treatments
What They Treat
Multiple sclerosis
How They Treat It
Neurological consultationDisease managementNeuro-ophthalmologyOptical coherence tomographyVisual field testingMS-centric physical therapyMobility assessmentsSpasticity managementBotox treatmentIntrathecal baclofen pump managementInfusionsPhlebotomy servicesDisease educationCoordination of careClinical trialsBotoxIntrathecal baclofen pumpInfusionsPhlebotomy
Diagnostics
Optical coherence tomographyVisual field testingComputerized visual fields
Research & Clinical Trials
This center is currently involved in 13 clinical trials — ranked #1 in Oklahoma for active trials
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
Ocrelizumab
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibTeriflunomidePlacebo
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
OcrelizumabOcrelizumabAntihistamineMethylprednisolone
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
ModernaTX, Inc.
RECRUITINGPHASE2
mRNA-1195Placebo
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
RemibrutinibTeriflunomide
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
OfatumumabTetanus toxoid (TT) containing vaccine (Td, Tdap)13-valent pneumococcal conjugate vaccine (13-PCV)23-valent pneumococcal polysaccharide vaccine (23-PPV)Seasonal Quadrivalent influenza vaccineKeyhole limpet hemocyanin (KLH) neo-antigen
MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect
Ad scientiam
ACTIVE NOT RECRUITINGNA
MSCopilot® Detect mobile application
MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integration in Patients' pathWay and Users' ExpeRience
Ad scientiam
ACTIVE NOT RECRUITINGNA
MSCopilot Flower mobile application
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)
RECRUITINGPHASE4
OcrelizumabPlacebo for Ocrelizumab
Skeletal Muscle Aging and Responsiveness in Aged People With MS
Oklahoma Medical Research Foundation
RECRUITINGNA
Exercise trial consisting of both cardiovascular and strength training
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Johns Hopkins University
ACTIVE NOT RECRUITINGNA
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod
Insurance & Access
Insurance & Support
Financial Counseling
Care Coordinator
Related MS Research
Recent studies relevant to this center's focus areas
FAQs from OMRF Multiple Sclerosis Center of Excellence
The center offers neurological consultation, disease management, neuro-ophthalmology care, MS-centric physical therapy, mobility assessments, and spasticity management. It also provides disease education and coordination of care.
Yes. The center has on-site infusion services, along with phlebotomy services and treatment support for patients who need regular infusion-based care.
The team includes neurologists, physician assistants, physical therapy, and social work. Named providers include Gabriel Pardo, Yang Mao-Draayer, Chelsea Berkley, Tony Sharp, Jennifer Smith, Bobbette Miller, and Lauren Still.
The center offers neuro-ophthalmology care, optical coherence tomography, visual field testing, and computerized visual fields. These services help evaluate vision-related concerns that can come with MS.
Yes. A doctor referral is required before becoming a patient at the center. The facility also provides patient forms, and reserved parking is available in Garage 15T.
Compare Oklahoma MS Centers
| Center | Type | Infusion | Virtual | Experience |
|---|---|---|---|---|
OMRF Multiple Sclerosis Center of Excellence Oklahoma City | Academic MS Center | ✓ | — | 3.6/5 |
MS Center of Oklahoma, Mercy Neuroscience Institute Oklahoma City | Community Hospital Program | — | — | 2.6/5 |
OMRF Multiple Sclerosis Center of Excellence
Oklahoma City • Academic MS Center
Infusion
✓
Virtual
—
Experience
3.6/5
MS Center of Oklahoma, Mercy Neuroscience Institute
Oklahoma City • Community Hospital Program
Infusion
—
Virtual
—
Experience
2.6/5
MS Centers Across the U.S.
Click a state to browse its MS treatment centers.
Check out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
Information on this page is compiled from public sources including facility websites, ClinicalTrials.gov, CMS data, and AI analysis. It may not be complete or current. Always verify directly with the facility.